Drug Discovery

Biomarket Trends: Pain Therapeutics Sector Ripe with Potential

Pain affects all of us sometimes and many of us all the time. Yet, the pharmacologic therapies available to alleviate pain have changed little...

Company Update: Engineering Solutions for Drug Discovery

Pharma and biotech companies often require innovative systems and equipment to achieve their goals in drug discovery, development, and manufacturing. TTP LabTech provides custom...

Using AMDE Data to Cut Drug Toxicology Failures

Getting human ADME/Tox data at the early stages of drug development could have substantial payoffs in terms of lowering lead candidates’ toxicology. Developing in...

Biomarkers Transform R&D

FDA defines a biomarker as a characteristic “objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to...

Trends in Mass Spec: Understanding a Drug’s Metabolic Profile

The annual meeting of the American Association of Mass Spectrometry held in June featured the debut of many improved and modified mass spec instruments...

David Weiner, Ph.D.

from the University of Pennsylvania School of Medicine and Editor of DNA and Cell Biology - a peer-review journal published by Mary Ann Liebert, Inc. - talks with GEN's Editor-in-Chief John Sterling about DNA vaccines.

Dr. Una Ryan

- from Avant Immunotherapeutics, talks with GEN's Editor-in-Chief John Sterling about recent developments in vaccine research.

Assay Tutorial: Adenoviral Vector Gene Delivery System

Biological assays in established and primary cells can greatly aid the drug discovery process. Stable cell (inheritable genotype) lines are chosen for their consistent...